About: How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey
Creator	Albano, Francesco Breccia, Massimo Fazi, Paola Finazzi, Guido Iurlo, Alessandra Martino, Bruno Palandri, Francesca Passamonti, Francesco Piciocchi, Alfonso Siragusa, Sergio Soddu, Stefano Vannucchi, Alessandro Marco Vignetti, • Valerio De Stefano, •
source	Medline; PMC
abstract	covid:9ba8f6ee5358afb723367f12f57f1de3d105c1db#abstract
has issue date	2020-07-03(xsd:dateTime)
bibo:doi	10.1038/s41375-020-0953-3
bibo:pmid	32620840
has license	cc-by
sha1sum (hex)	9ba8f6ee5358afb723367f12f57f1de3d105c1db
schema:url	https://doi.org/10.1038/s41375-020-0953-3
resource representing a document's title	How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey
has PubMed Central identifier	PMC7333222
has PubMed identifier	32620840
schema:publication	Leukemia
resource representing a document's body	covid:9ba8f6ee5358afb723367f12f57f1de3d105c1db#body_text
is schema:about of	named entity 'pandemic' named entity 'neoplasms' named entity 'myeloproliferative neoplasms' named entity 'polycythemia vera' named entity 'essential thrombocythemia' named entity 'cytokine' named entity 'thrombotic' named entity 'pharyngeal' named entity 'Creative Commons license' named entity 'COVID-19' named entity 'JAK1' named entity 'MPNs' named entity 'high-risk' named entity 'Creative Commons license' named entity 'ruxolitinib' named entity 'IFN' named entity 'hematologists' named entity 'COVID' named entity 'Italian' named entity 'asymptomatic patients' named entity 'biopsy' named entity 'pharyngeal' named entity 'ruxolitinib' named entity 'COVID' named entity 'Open Access' named entity 'infection' named entity 'MPN' named entity 'immunosuppression' named entity 'myeloproliferative neoplasms' named entity 'phlebotomies' named entity 'cardiovascular risk factors' named entity 'Scientific Working Group' named entity 'hematologists' named entity 'thrombotic' named entity 'NK cells' named entity 'ruxolitinib' named entity 'follow-up' named entity 'MPN' named entity 'ruxolitinib' named entity 'coronavirus disease 2019' named entity 'hematologists' named entity 'disease burden' named entity 'MPN' named entity 'Gruppo Italiano' named entity 'ruxolitinib' named entity 'pharyngeal' named entity 'Creative Commons license' named entity 'COVID-19 pandemic' named entity 'Blood and Marrow Transplantation' named entity 'MPL' named entity 'MPNs' named entity 'MPNs' named entity 'tyrosine kinase inhibitors' named entity 'interferon' named entity 'hematologists' named entity 'infection' named entity 'COVID-19' named entity 'hematologists' named entity 'COVID' named entity 'ruxolitinib' named entity 'histology' named entity 'Italy' named entity 'IFN' named entity 'COVID' named entity 'COVID-19' named entity 'CALR' named entity 'Creative Commons Attribution 4.0' named entity 'Hematologists'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software